Synonyms: GSK-2636771
Compound class:
Synthetic organic
Comment: GSK2636771 is a potent, orally bioavailable, PI3Kβ-selective inhibitor, with anticancer effects in PTEN null cells [2].
|
|
References |
1. Lin S, Jin J, Liu Y, Tian H, Zhang Y, Fu R, Zhang J, Wang M, Du T, Ji M et al.. (2019)
Discovery of 4-Methylquinazoline Based PI3K Inhibitors for the Potential Treatment of Idiopathic Pulmonary Fibrosis. J Med Chem, 62 (19): 8873-8879. [PMID:31335136] |
2. Macauley D, Fernandez R, Colombo A. (2012)
American Association for Cancer Research (AACR) 103rd Annual Meeting, Chicago, Illinois, USA – March 31-April 4, 2012. Drugs of the Future, 37 (6): 451. |
3. Weigelt B, Warne PH, Lambros MB, Reis-Filho JS, Downward J. (2013)
PI3K pathway dependencies in endometrioid endometrial cancer cell lines. Clin Cancer Res, 19 (13): 3533-44. [PMID:23674493] |